First-in-human clinical trial of CAR T cell therapy with new binding mechanism shows promising early responses
Newswise — SAN DIEGO – Early results from a Phase I clinical trial of AT101, a new CAR T cell therapy that uses a distinct binding mechanism to…
Read more First-in-human clinical trial of CAR T cell therapy with new binding mechanism shows promising early responses